Evaluating vascular aging after COVID-19 infection
Official title: Covid-19 Effects on ARTErial StIffness and Vascular AgiNg
Run by Assistance Publique - Hôpitaux de Paris · NCT04558450 · Data updated 2026-11-12
This study is testing how COVID-19 affects blood vessel health and aging in adults by checking their heart and blood vessel function six and twelve months after infection.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 3 sites (Nancy and 2 other locations) |
| Status | Recruiting |
| Started | September 21, 2020 |
| Main results expected | March 2023 |
| Study ends | March 2033 |
| Registry record updated | November 22, 2021 |
| Trial ID | NCT04558450 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old who have recently been diagnosed with COVID-19 and have varying hospitalization experiences.
✕Probably not a fit
Patients under 18 years old, those unable to provide consent, or with life-limiting conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effects of COVID-19 on arterial stiffness and vascular aging by conducting non-invasive evaluations of vascular and cardiac function in patients six and twelve months post-infection. Eligible participants will include adults diagnosed with COVID-19, with varying degrees of hospitalization, and will undergo assessments to measure carotid-femoral pulse-wave velocity. Additionally, cardiovascular events and mortality data will be collected over a period of 10 years to understand long-term impacts.
Why it matters
Potential benefit: If successful, this study could provide insights into the long-term cardiovascular effects of COVID-19, potentially leading to improved management and treatment strategies for affected patients.
How similar studies have gone: Other studies have explored the cardiovascular effects of COVID-19, indicating a growing body of evidence, but this specific approach to vascular aging is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age \>18 years, both sexes; * written informed consent; * affiliation to a social security regime; * a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3) * hospitalization in intensive care unit for COVID19 (for group 1) * hospitalization in a medicine unit for COVID19 (for group 2) * no hospitalization for COVID19 or hospitalization less than 24h (for group 3) * a negative test for SARS-nCOV2 infection (PCR or serology)(for group 4) Exclusion Criteria: * Age \<18 years * Inability to express consent of the study * Diseases carrying out a life -expectancy \<1 year according to clinical judgment * Pregnancy and breastfeeding * Foreseen inability to attend scheduled visits
Where it's running
-
CHRU Nancy
Nancy, France Recruiting -
Hôpital Européen Georges Pompidou - APHP
Paris, France Recruiting -
CHU Rouen
Rouen, France Recruiting
Study contacts
- Principal investigator: Pierre BOUTOUYRIE, MD PHD — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Rosa Maria BRUNO, MD
- Email: rosa-maria.bruno@inserm.fr
- Phone: +33 1 53 98 79 67
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How Lipoprotein(a) affects artery stiffness, blood vessel lining, and heart muscle movement
This project will see if higher Lipoprotein(a) levels are linked to stiffer arteries, worse endothelial function, and changes in left atrial and left ventricular motion in adults 18–75.
-
Cytisine treatment for helping smokers quit and its effects on heart health
This study tests if a plant-based treatment called cytisine can help adult smokers quit and also looks at how it affects their heart health during and after the treatment.
-
Understanding the role of glycocalyx integrity in preventing major cardiovascular events
This study is looking to see if the health of a protective layer in blood vessels can help prevent serious heart problems in people getting routine check-ups.
-
Sleep and arterial function in hypertensive patients with poor sleep quality
This trial tests whether using cognitive-behavioural therapy for insomnia can improve artery health and well-being in adults with high blood pressure and poor sleep.
-
Can mouth health and chewing help explain arterial stiffness in healthy adults
This study tests whether a profile of oral health and function adds information about central arterial stiffness beyond traditional risk factors in healthy adults.
-
Endothelial extracellular vesicles in kids with newly diagnosed high blood pressure
This study tests whether levels of endothelial extracellular vesicles are different in children with new, untreated primary hypertension compared to normotensive children.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.